Sfoglia per Rivista
Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate.
1990-01-01 Monti, ELENA CATERINA; Paracchini, Luisa; Piccinini, F; Malatesta, V; Morazzoni, F; Supino, R.
In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects
2011-01-01 Zanellato, I; Boidi, Cd; Lingua, G; Betta, Pg; Orecchia, S; Monti, ELENA CATERINA; Osella, D.
Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in rat.
1986-01-01 Monti, ELENA CATERINA; Piccinini, F; Villani, F; Favalli, L.
Prevention of doxorubicin-induced cardiomyopathy by reduced glutathione.
1991-01-01 Villani, F; Galimberti, M; Zunino, F; Monti, ELENA CATERINA; Rozza, A; Lanza, E; Favalli, L; Poggi, P.
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
2012-01-01 Grossi, F; Rijavec, E; Dal Bello, Mg; Defferrari, C; Brianti, A; Barletta, G; Genova, C; Murolo, C; Cosso, M; Fontanini, G; Boldrini, L; Truini, M; Pronzato, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate. | 1-gen-1990 | Monti, ELENA CATERINA; Paracchini, Luisa; Piccinini, F; Malatesta, V; Morazzoni, F; Supino, R. | |
In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects | 1-gen-2011 | Zanellato, I; Boidi, Cd; Lingua, G; Betta, Pg; Orecchia, S; Monti, ELENA CATERINA; Osella, D. | |
Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in rat. | 1-gen-1986 | Monti, ELENA CATERINA; Piccinini, F; Villani, F; Favalli, L. | |
Prevention of doxorubicin-induced cardiomyopathy by reduced glutathione. | 1-gen-1991 | Villani, F; Galimberti, M; Zunino, F; Monti, ELENA CATERINA; Rozza, A; Lanza, E; Favalli, L; Poggi, P. | |
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib | 1-gen-2012 | Grossi, F; Rijavec, E; Dal Bello, Mg; Defferrari, C; Brianti, A; Barletta, G; Genova, C; Murolo, C; Cosso, M; Fontanini, G; Boldrini, L; Truini, M; Pronzato, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile